Workflow
United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis
Businesswire· 2025-09-19 19:00
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will host a webcast to review data from the successful TETON-2 pivotal study evaluating the use of nebulized Tyvaso® (treprostinil) Inhalation Solution for the treatment of idiopathic pulmonary fibrosis (IPF) on Sunday, September 28, 2025, at 12:30 p.m. Eastern Time. During the webcast, Steven D. Nathan, M.D., Schar Chair, Advanced Lung Disease and Lung Tran. ...
Bitcoin Price Slides. Why It's Still Been a Good Week for Cryptos.
Barrons· 2025-09-19 19:00
There was no obvious factor dragging prices lower, although investors may have been taking the chance to lock in some profit. ...
Emerita Granted Two Additional Properties in the IBW Area, “San Antonio” and “Terranova” Exploration Permits and Enters Into Agreement to Acquire the Nueva Celti Project in Andalusia, Spain
Globenewswire· 2025-09-19 19:00
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) is pleased to announce that the Ministry of Industrial Policy and Energy of Huelva, Andalusia has granted the Company exploration permits for the San Antonio and Terranova claims (collectively, the “New Properties”) (Figure 1). These New Properties add an additional 181 hectares to Emerita’s wholly owned Iberian Pyrite Belt holdings. The New Properties are adjacent to the Ib ...
Ask an Advisor: Can I Retire at 62 With $680k in a 401(k), $1,600 Monthly Pension and $150k in Cash?
Yahoo Finance· 2025-09-19 19:00
退休收入构成分析 - 养老金年收入为19200美元 提供稳定的基础收入来源[3] - 401(k)和储蓄账户总额达830000美元 按4%规则首年可提取33200美元[4] - 养老金与账户提取合计年收入达52400美元 税后约48000美元[4] 社会保障金测算 - 假设62岁退休且最后年薪40000美元时 年社保收入范围未具体披露但使总收入达63740-74216美元[6] - 最后年薪70000美元时 62岁/67岁/70岁领取社保的年收入分别为11340美元/17064美元/21816美元[7] - 社保福利显著提升总收入水平 最高可使年收入增加21816美元[6][7] 综合财务规划 - 未计算社保前 月度可支配收入约4000美元[5] - 总退休收入需结合个人支出水平和社会保障金领取时点综合评估[2] - 建议通过专业财务顾问进行个性化退休规划[2][5]
Samsung, in Collaboration with Niio, Inspires with “Code of Nature” on The Wall LED in Samsung Germany's Office Lobby
Globenewswire· 2025-09-19 19:00
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Samsung Electronics, in collaboration with Niio, unveils Code of Nature — an immersive, generative digital art installation designed for The Wall LED display in the lobby of its Germany office in Eschborn. This striking installation transforms the space into a living canvas, reflecting Samsung’s commitment to innovation, culture, and its local presence. Created by renowned digital artist Ronen Tanchum of Phenomena Labs and curated with Niio — the global platform ...
A2Z Cust2Mate Completes Oversubscribed $45 Million Equity Raise, Anchored by Leading Global Financial Institutions
Accessnewswire· 2025-09-19 19:00
Following $80 Million in Global Orders; Smart Cart Company Now Fully Funded to Execute Growth Strategy TEL AVIV, IL / ACCESS Newswire / September 19, 2025 / A2Z Cust2Mate Solutions Corp. (NASDAQ:AZ), a global leader in smart retail technology, today announced the completion of a $45 million equity financing round at $8.00 per share, which was oversubscribed due to strong demand from top-tier investors. The offering was anchored by some of the world's most prominent financial institutions-Wellington Manageme ...
TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)
Businesswire· 2025-09-19 19:00
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Sobi® today announced that TRYNGOLZA® (olezarsen) has been approved in the European Union (EU) as an adjunct to diet in adult patients for the treatment of genetically confirmed familial chylomicronemia syndrome (FCS). The approval follows the positive opinion of the Committee for Medicinal Products for Human Use. The approval is based on positive data from the Phase 3 Balance study, in which TRYNGOLZA 80 mg demon. ...
Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025
Businesswire· 2025-09-19 18:59
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025. ...
SBI Foundation to support 23,230 meritorious students under Asha Scholarship; commits ₹90 crore
BusinessLine· 2025-09-19 18:58
SBI Foundation, the CSR arm of the State Bank of India (SBI), has launched the SBI Platinum Jubilee Asha Scholarship 2025, with a commitment of ₹90 crore in FY26. India’s largest bank, in a statement, said this year the SBI Asha Scholarship, which was instituted in 2022, will empower 23,230 meritorious students from humble and underprivileged backgrounds across India, making higher education accessible to them.The scholarship covers students from Class 9 onwards up to postgraduate programmes, offering finan ...
Why Is Crypto Down Today? – September 19, 2025
Yahoo Finance· 2025-09-19 18:57
The crypto market is down today, with the global market cap falling by 0.8% to $4.17 trillion. Trading volume is also lower, now sitting at $143.7 billion. Most of the top cryptocurrencies are showing red on the 24-hour chart. TLDR: 8 of the top 10 cryptocurrencies are in the red today; BTC is down 0.6% to $116,601, ETH drops 1.6% to $4,522; CryptoQuant analyst expects BTC consolidation for 1–2 weeks; Michigan advances Bitcoin Reserve Bill (HB 4087); Bitunix says the bill boosts risk appetite sho ...